|
Q4 2021
Filed on Jan 21, 2022
|
14,865
|
$10.62 - $11.47
$158K - $171K
|
|
Dicerna Pharmaceuticals Inc
|
Q4 2021
Filed on Jan 21, 2022
|
206,845
|
N/A
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
44,171
|
N/A
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
13,109
|
N/A
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
630,000
|
N/A
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
329,000
|
N/A
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
5,275
|
N/A
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
441,818
|
$1.66 - $2.64
$733K - $1.17M
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
322,565
|
$2.6 - $4.36
$839K - $1.41M
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
5,621
|
N/A
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
19,692
|
$5.31 - $6.87
$105K - $135K
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
466
|
$4.91 - $34.12
$2.29K - $15.9K
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
214,100
|
$3.57 - $5.45
$764K - $1.17M
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
101,412
|
N/A
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
81,300
|
$2.1 - $5.1
$171K - $415K
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
138,453
|
$5.81 - $8.03
$804K - $1.11M
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
26,525
|
N/A
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
218,100
|
$2.15 - $2.79
$469K - $608K
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
1,441,120
|
N/A
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
3,898
|
$5.18 - $7.24
$20.2K - $28.2K
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
100,814
|
N/A
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
98,100
|
$10.03 - $10.7
$984K - $1.05M
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
2,013,000
|
N/A
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
51,371
|
$13.72 - $20.8
$705K - $1.07M
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
380,709
|
N/A
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
42,871
|
$6.53 - $14.19
$280K - $608K
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
135,057
|
$9.17 - $16.39
$1.24M - $2.21M
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
139,396
|
$2.69 - $4.42
$375K - $616K
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
8,187
|
N/A
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
160,000
|
$1.77 - $2.19
$283K - $350K
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
200,806
|
$8.33 - $12.14
$1.67M - $2.44M
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
78,150
|
$9.7 - $10.0
$758K - $782K
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
1,594
|
$22.99 - $26.5
$36.6K - $42.2K
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
235,000
|
N/A
|
|
|
Q4 2021
Filed on Jan 21, 2022
|
413,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 08, 2021
|
1,400
|
N/A
|
|
Alaska Communications Systems Group Inc
|
Q3 2021
Filed on Nov 08, 2021
|
450,748
|
N/A
|
|
Alexion Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 08, 2021
|
216,189
|
N/A
|
|
|
Q3 2021
Filed on Nov 08, 2021
|
10,637
|
$34.57 - $39.06
$368K - $415K
|
|
Boston Private Financial Holdings Inc
|
Q3 2021
Filed on Nov 08, 2021
|
15,303
|
N/A
|
|
Bristol Myers Squibb Company
|
Q3 2021
Filed on Nov 08, 2021
|
233,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 08, 2021
|
8,983
|
N/A
|
|
|
Q3 2021
Filed on Nov 08, 2021
|
2,898
|
$13.18 - $19.83
$38.2K - $57.5K
|
|
|
Q3 2021
Filed on Nov 08, 2021
|
794
|
$231.17 - $262.57
$184K - $208K
|
|
Core Mark Holding Company Inc
|
Q3 2021
Filed on Nov 08, 2021
|
104,397
|
N/A
|
|
|
Q3 2021
Filed on Nov 08, 2021
|
1,131,014
|
N/A
|
|
|
Q3 2021
Filed on Nov 08, 2021
|
3,160,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 08, 2021
|
6,083,183
|
N/A
|
|
|
Q3 2021
Filed on Nov 08, 2021
|
44,283
|
N/A
|
|
|
Q3 2021
Filed on Nov 08, 2021
|
322,861
|
$0.45 - $0.78
$145K - $252K
|
|